UBA2 and cancer: Together, these results suggest that impairment of the SUMO pathway is impacting proliferation and viability at multiple biological nodes including DNA decatenation, mitosis and PML nuclear body organization, which in sum likely contribute to the proliferation defects observed in the SAE2 knockdown cancer cells.